This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,155,075 units of the pharmaceutical product Ondansetron ODT 4 mg Tablet in 30-count packages. The contract has a completion date of December 21, 2023 and a potential value of $4,456.67. No set-aside designation was used. Amerisourcebergen Drug Corporation, through its Corporate Office division, has a history of providing pharmaceuticals, medical supplies, and distribution services to support U.S. Department of Defense medical programs and facilities. This delivery order falls under Amerisourcebergen's broader indefinite delivery contract with the DLA to supply a range of pharmaceutical and medical products.
Generated 3/20/24, 5:41 PM